1. WOMAN Trial Collaborators. 2017. Lancet. 389(10084):2105–2116.

​

2. Updated WHO Recommendation on Tranexamic Acid for the Treatment of Postpartum Haemorrhage. Highlights and Key Messages from the World Health Organization’s 2017 Global Recommendation.

​

3. The CRASH-2 collaborators; Effects of TXA on death, vascular occulsive events, and blood transfusions in traumapatients with significant haemorrhage (CRASH-2): a randomized, placebo-controlledtrial.Lancet 2010; 376: 23–32.

​

4. The CRASH-2 collaborators; The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011; 377: 1096–101.

​

5. The CRASH-3 trial collaborators; Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet 2019; 394: 1713.

​

6. Size and distribution of the global volume of surgery in 2012. Bull World Health Organ 2016;94:201–209F.

​

7. Katharine Ker, Phil Edwards, Pablo Perel, Haleema Shakur, Ian Roberts. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ 2012;344:e3054.

​

8. NICE Guidelines: Blood Transfusion NG24. August 2023.

​

9. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology and Intensive Care. Eur J Anaesthesiol 2023; 40:226-304.

​

10. Practice Guidelines for Perioperative Blood Management An Updated Report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management. Anesthesiology, V 122 • No 2 241 February 2015.

​

11. Spanish Consensus Statement on alternatives to allogeneic blood transfusion: the 2013 update of the "Seville Document".  Blood Transfus 2013; 11: 585-610.

​

12. Traxamil®

TRAXAMIL® Ácido tranexámico

SALVA VIDAS con TRAXAMIL®

Reg. Sanitario No. 253M2024 SSA IV 

Información exclusiva para el profesional de la salud